● Rejection of Covid-19 vaccine: Northern group backs Kogi go

● Rejection of Covid-19 vaccine: Northern group backs Kogi go

From Noah Ebije, Kaduna


A northern group underneath the auspices of CITAR, a non-governmental organisation has declared its stand with the Kogi State governor, Yahaya Bello, over the rejection of Covid-19 vaccines, saying that there’s nothing incorrect with the governor doing so on behalf of the folks of the state.

Governor Bello had early this month introduced that his administration would not reply to the second wave of Covid-19 with worry and panic.

The governor went a step additional to reject the vaccines and additionally warned the folks in opposition to accepting to take them.

In a press release, spokesman of CITAR, Hayatu Girie, mentioned: “For a governor of a state to take a stand to reject the Covid-19 vaccines present that he has related and impeccable data that some of us don’t have about the virus.

“We, subsequently, don’t have any purpose to doubt Governor Yahaya Bello. He is an genuine supply of data and he ought to be relied upon.

“We don’t see him endangering the lives of his folks if he’s not in possession of details about the real nature or in any other case of the vaccines.

“We additionally agreed with Governor Bello on a report on June 30, 2020, that Covid-19 is a synthetic creation geared toward inflicting worry and panic amongst the folks.

“We also agreed with him when he spoke at the third-day prayers for the state Chief Judge, Justice Nasir Ajana, that the chief judge did not die of coronavirus.”

The group described the governor’s recommendation to residents not to present in to worry and evil of the points of Covid-19 as welcome recommendation.

Don’t forget to like our page on Facebook and Follow us on Twitter for more and latest updates.

Also note that this post does not reflect the views of Nairalovers. If you feel this post violated some policies, do not hesitate to Contact us with evidence and it will be taken down. See our Declaimer for more.

Be the first to get updated. Subscribe to our newsletter

Share This Post

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>

Enter Captcha Here :